Skip to main content
Blackhawk Growth Corp. logo

Blackhawk Growth Corp. — Investor Relations & Filings

Ticker · BLR ISIN · CA09238B3083 LEI · 875500A5R3SVGXL39M70 CSE Financial and insurance activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2022-01-12 Regulatory Filings
Country CA Canada
Listing CSE BLR

About Blackhawk Growth Corp.

https://www.blackhawkgrowthcorp.com/

Blackhawk Growth Corp. operates as an investment issuer, specializing in generating shareholder value through strategic investments in the technology and life sciences sectors. The company focuses on acquiring and developing assets, intellectual property, and projects related to medical technologies, pharmaceuticals, digital health, software, big data, and AI. Blackhawk seeks opportunities that demonstrate global scalability and potential for positive impact on health and human wellbeing. Its core strategy involves providing capital for R&D and commercialization, followed by value realization through mergers, acquisitions, divestments, or spin-outs and public listings on North American stock exchanges.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2022-01-12 English
News release - English.pdf
Regulatory Filings
2022-01-12 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Blackhawk Growth Corp. It provides detailed information about a material change event, specifically an operational update and financial summary of its subsidiary TERP Wholesale LLC. The form and content indicate it is a regulatory disclosure about a material change rather than a full financial report or earnings release. The document is approximately 4985 characters, which is relatively short but contains substantive information about the material change. This type of filing is typically categorized under Regulatory Filings (RNS) as it does not fit the definitions of Annual Report, Earnings Release, or other specific categories. It is a formal regulatory disclosure of a material change event as required by securities regulations.
2022-01-06 English
News release - English.pdf
Interim / Quarterly Report Classification · 85% confidence The document is a press release providing an operational and financial update on a subsidiary, TERP Wholesale LLC, including unaudited revenue and profit figures for the nine months ended September 30, 2021. It includes forward-looking statements and business updates but does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report. It is not an earnings release since it provides more detailed operational context and unaudited financials rather than just key highlights. The document is longer than 5,000 characters and contains substantive financial data, but it is primarily an operational update with unaudited figures rather than a formal financial report. Therefore, the best fit is an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with substantive financial data and analysis, despite being unaudited and presented as an update. 9M 2021
2022-01-06 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and includes detailed information about a material change involving Blackhawk Growth Corp. It references a news release dated January 4, 2022, and provides a full description of the material change related to the development of proprietary drug delivery technology. The form 51-102F3 is a regulatory filing used in Canadian securities regulation to disclose material changes. The document is relatively short (4163 characters) and is a formal regulatory disclosure of a material change, not a financial report, earnings release, or other types of filings. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-01-05 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing a new development by Blackhawk Growth Corp's subsidiary MindBio Therapeutics in drug delivery technology for psychedelic medicines. It discusses clinical trials, company strategy, and future plans but does not contain any financial data, regulatory filings, or detailed financial reports. It is an announcement of a business development rather than a formal financial or regulatory filing. The document length is about 4996 characters, and it is clearly a corporate announcement or news release. Therefore, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2022-01-05 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.